Regeneron News and Research

RSS
BioMed Realty Trust reports increased revenues of $93.0 million for the third quarter

BioMed Realty Trust reports increased revenues of $93.0 million for the third quarter

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept

Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept

New cancer stem cell identified behind metastatic tumors

New cancer stem cell identified behind metastatic tumors

BioMed Realty Trust embarks on $145 million expansion at Eastview

BioMed Realty Trust embarks on $145 million expansion at Eastview

Two novel therapies for multiple myeloma

Two novel therapies for multiple myeloma

NIH launches "Knockout Mouse Project"

NIH launches "Knockout Mouse Project"

ZymoGenetics files lawsuit against Bristol-Myers Squibb

ZymoGenetics files lawsuit against Bristol-Myers Squibb

Secrets of how the brain is wired for sex revealed

Secrets of how the brain is wired for sex revealed